Subunit interactions influence the biochemical and biological properties of Hsp104 by Schirmer, Eric et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subunit interactions influence the biochemical and biological
properties of Hsp104
Citation for published version:
Schirmer, EC, Ware, DM, Queitsch, C, Kowal, AS, Lindquist, SL & Schirmer, E 2001, 'Subunit interactions
influence the biochemical and biological properties of Hsp104' Proceedings of the National Academy of
Sciences of the United States of America - PNAS, vol 98, no. 3, pp. 914-9., 10.1073/pnas.031568098
Digital Object Identifier (DOI):
10.1073/pnas.031568098
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher final version (usually the publisher pdf)
Published In:
Proceedings of the National Academy of Sciences of the United States of America - PNAS
Publisher Rights Statement:
Free in PMC.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
Subunit interactions influence the biochemical and
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Point mutations in either of the two nucleotide-binding domains
(NBD) of Hsp104 (NBD1 and NBD2) eliminate its thermotolerance
function in vivo. In vitro, NBD1 mutations virtually eliminate ATP
hydrolysis with little effect on hexamerization; analogous NBD2
mutations reduce ATPase activity and severely impair hexameriza-
tion. We report that high protein concentrations overcome the
assembly defects of NBD2 mutants and increase ATP hydrolysis
severalfold, changing Vmax with little effect on Km. In a comple-
mentary fashion, the detergent 3-[(3-cholamidopropyl)dimethyl-
ammonio]-1-propanesulfonate inhibits hexamerization of wild-
type (WT) Hsp104, lowering Vmax with little effect on Km. ATP
hydrolysis exhibits a Hill coefficient between 1.5 and 2, indicating
that it is influenced by cooperative subunit interactions. To further
analyze the effects of subunit interactions on Hsp104, we assessed
the effects of mutant Hsp104 proteins on WT Hsp104 activities. An
NBD1 mutant that hexamerizes but does not hydrolyze ATP re-
duces the ATPase activity of WT Hsp104 in vitro. In vivo, this mutant
is not toxic but specifically inhibits the thermotolerance function of
WT Hsp104. Thus, interactions between subunits influence the
ATPase activity of Hsp104, play a vital role in its biological func-
tions, and provide a mechanism for conditionally inactivating
Hsp104 function in vivo.
The HSP100yClp family of chaperone proteins plays a widevariety of important cellular roles in different organisms,
including survival of environmental stress, regulation of genetic
competence, transposition, proteolysis, and control of a protein-
based genetic element (prion). These seemingly unrelated roles
are unified by a common remarkable biochemical mechanism;
the proteins promote the disassembly of aggregated proteins and
higher-order protein complexes (reviewed in refs. 1 and 2).
Several biochemical properties are shared by HSP100 proteins
and are required for their biological functions, suggesting that
these properties are important to the complex phenomenon of
protein disassembly. These properties include an ATP-
hydrolyzing activity (3–10) and the ability to self-assemble into
oligomers, primarily hexamers (11–13).
A member of the HSP100 family from Saccharomyces cerevi-
siae, Hsp104, is critical for survival after exposure to extreme
temperatures (50°C) (14) or high concentrations of ethanol
(20%) (15). These stresses cause protein denaturation, and
Hsp104 promotes survival by facilitating the resolubilization of
heat-damaged, aggregated proteins (reviewed in refs. 1 and 2).
At normal temperatures, Hsp104 plays a critical role in the
inheritance of the novel proteinaceous genetic element [PSI1]
(often called a yeast prion), an ordered aggregate of the trans-
lation terminator, Sup35 (16).
Hsp104 is a member of the class 1 HSP100 proteins, with two
distinct but highly conserved nucleotide-binding domains
(NBDs) (1, 17). NBD1 and NBD2 of Hsp104 show only 22%
amino acid identity with each other, yet each shares 40–60%
identity with the corresponding domains of their Escherichia coli
relatives, ClpA and ClpB (18). Although NBD1 and NBD2 are
very different from each other, both contain classic Walker-type
consensus sequences for the P-loop (19) that resemble those of
NSF and the P-type transporter protein families. ATP promotes
the assembly of Hsp104 into hexamers (11), and Hsp104 hydro-
lyzes ATP with a high degree of specificity (10). The mechanism
by which Hsp104 performs its functions is not understood.
However, both its ATPase activity and its oligomerization
properties seem to be essential. Point mutations that perturb
these functions (10, 11) eliminate the ability of Hsp104 to
provide thermotolerance (20) and interfere with the normal
metabolism of the [PSI1] element (16).
Previously, we reported that canonical P-loop residue muta-
tions in NBD1 of Hsp104 virtually eliminate ATP hydrolysis but
have little effect on oligomerization. In contrast, analogous
mutations in NBD2 inhibit but do not eliminate ATP hydrolysis
and severely impair oligomerization (10, 11). Based upon the
crystal structures and mutational analysis of other Walker-type
ATP binding sites (21), these mutations were chosen to inhibit
ATP binding without perturbing the general structure of the
domain. The related E. coli protein, ClpA, is similar to Hsp104
in that analogous point mutations in NBD1 and NBD2 differ-
ently affect oligomerization and ATP hydrolysis (22, 23). Curi-
ously, however, the effects of the mutations are reversed from
those reported for Hsp104 (10). Either the two domains have
independent functions (one responsible for ATP hydrolysis, the
other for oligomerization) and these functions have switched in
the two proteins during the course of evolution or both domains
contribute to ATP hydrolysis and oligomerization in a complex,
interdependent manner, and other differences between the two
proteins idiosyncratically cause analogous mutations to perturb
one of these characteristics more than the other. Indeed, mu-
tations that abolish oligomerization in Hsp104 or in ClpA also
reduce ATP hydrolysis (10, 22, 23), suggesting a relationship
between oligomerization and ATP hydrolysis. However, no
kinetic information is available relating these properties in any
HSP100 protein nor relating subunit interactions to biological
function.
Here, we demonstrate that interactions between Hsp104
subunits increase the ATPase activity of Hsp104 in a cooperative
fashion. We also report that Hsp104 proteins that carry point
mutations in NBD1 or NBD2 profoundly alter the activities of
wild-type (WT) Hsp104 in mixed oligomers and do so in
different ways both in vitro and in vivo. The data support previous
suggestions of functional distinctions in the two NBDs, illustrate
the importance of proper subunit interactions in establishing the
functional state of Hsp104, and provide different ways to alter
that state.
Materials and Methods
Plasmids. Point mutations in HSP104 were produced and placed
into expression vectors as described (10). Mutant HSP104 coding
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sequences were inserted behind the yeast glyceraldehyde-3-
phosphate dehydrogenase promoter in pRS305 for integration at
the LEU2 locus. The WT HSP104 coding sequence was placed
under Gal1 regulation in pRS316 (cen6yars4, URA3; 104bU).
pHCAyGAL4(1–93).ER.VP16, which encodes a b-estradiol-
activated inducer of Gal1-regulated genes (24), was the gift of D.
Picard. Late in the course of these studies, we found that one of
the mutants, K218T, had acquired an additional mutation pro-
ducing K218T:A315T. This mutant behaved similarly to K218T
alone when retested for assembly and ATP hydrolysis.
Strains. The integration constructs described above and their
parent vector, pRS305 (cleaved with AflII), were integrated into
yeast strain MD104–1U in which 80% of the HSP104 coding
sequence is deleted. These strains were subsequently trans-
formed with two plasmids: pHCAyGAL4(1–93).ER.VP16 and
either pRS316 or 104bU. This generated strains with the follow-
ing combinations of integrated glyceraldehyde-3-phosphate de-
hydrogenase-regulated (constitutive)yplasmid b-estradiol-
regulated genes: vectoryvector, K218T:A315Tyvector, vectory
WT, K218T:A315TyWT, K620Tyvector, and K620TyWT.
Protein Purification. Hsp104 was purified from yeast and E. coli as
described (11, 25). To compare mutant and WT, proteins were
first dialyzed against and concentrated in 20 mM Hepes, pH
7.5y140 mM KCly15 mM NaCly10 mM MgCl2y2 mM DTT using
Ultrafree-15 centrifugal filter devices with Mr cut-off at 30,000
Da (Millipore). After concentrations were determined (25),
proteins were diluted in the same buffer.
ATPase Assays. To relate ATP hydrolysis to oligomerization, both
types of assay were performed in reaction buffer 1 (20 mM
Hepes, pH 7.5y140 mM KCly15 mM NaCly10 mM MgCl2). All
reactions included 5 mM ATP (pH 7.5) except for Km experi-
ments, where the reaction buffer, containing 5 mM MgCl2,
included Mg-ATP (0.01 to 40 mM). ATP and 3-[(3-cholamido-
propyl)dimethylammonio]-1-propanesulfonate (CHAPS) were
adjusted to pH 7.5.
All assays shown were performed, as described (10), for times
at which the phosphate released was linear for the assay system.
Released Pi was quantified with malachite green (26), and A650
was determined with a Molecular Devices Vmax kinetic micro-
plate reader with SOFTMAX software. Values were calibrated
against KH2PO4 standards and corrected for phosphate released
in the absence of Hsp104. For each point, at least three and
typically six independent assays were used to calculate the mean
and standard deviation. The curves shown and Km and Vmax
values (500 mM to 25 mM ATP) were generated by using least
squares fitting to the Michaelis–Menten equation with the
KALEIDAGRAPH graphics program (Synergy Software, Reading,
PA). Similar values were obtained when Lineweaver–Burke and
Eadie–Hofstee plots were used. For calculation of the Hill
coefficient (10 mM to 40 mM ATP), nonlinear curves fitted to
the Michaelis–Menten equation were generated by plotting the
rate of hydrolysis mg21 protein versus the concentration of ATP
using the nonlinear allosteric kinetic equation of the GRAFIT 4
graphics program (Erithacus Software, Surrey, U.K.).
Similar results were obtained with a second assay for which 5
mCi of [a-32P]ATP (3,000 MBq) was added per 25-ml reaction;
reactions were stopped by addition of formic acid to 1.5 M; ATP
and ADP were resolved on Baker-f lex cellulose PEI plates using
0.25 M LiCl, 0.375 M Tris, 1 M formic acid; and the percentage
of ATP hydrolyzed was determined from comparison of the
intensity of ADP and ATP spots with a Molecular Dynamics
PhosphorImager using IMAGEQUANT software.
Cross-Linking Assays. Wild-type and mutant proteins dialyzed
against reaction buffer 1 with 2 mM DTT were adjusted to the
indicated concentrations in reaction buffer 1 containing DTT (2
mM) with or without ATP (5 mM). Assay volumes were 200 ml
for 0.01 mgyml, 120 ml for 0.02 mgyml, 100 ml for 0.05 mgyml,
40 ml for 0.1 mgyml, and 10 ml for 0.5 mgyml reactions. Reactions
were incubated at 37°C for 10 min, glutaraldehyde was added
(final concentration 0.01%), and cross-linking was terminated as
described (11). Conditions were the same for experiments with
CHAPS except that 3 mM ATP was used instead of 5 mM.
Thermotolerance Assays. Cells were grown to equal logarithmic-
phase densities, the 104bU plasmid was induced with 100 nM
b-estradiol for 2 h, and aliquots were moved directly to 50°C for
4 min and then plated on noninducing media to determine
survival rates as described (27). During the heat shock, addi-
tional aliquots were taken for protein quantitation by Western
analysis as described (27), except that immune complexes re-
acted with 125I-labeled protein A were quantified by using a
Molecular Dynamics PhosphorImager and IMAGEQUANT
software.
Results
The Relationship Between Hexamerization and Protein Concentration.
In buffers that approximate physiological salt concentrations,
the assembly of Hsp104 into hexamers is driven by the addition
of adenine nucleotides (11). In the absence of added nucleotide,
Hsp104 forms hexamers if salt concentrations are low (i.e., 20
mM; ref. 10). We sought additional conditions that would
promote assembly in the absence of ATP and found that
increasing the protein concentration in physiological ionic
strength buffers did so (Fig. 1A). When Hsp104 was cross-linked
with glutaraldehyde at a protein concentration of 0.1 to 0.5
mgyml, most of the protein migrated on SDSyPAGE as a
hexamer (this is apparent from counting the steps in the ladder
of species obtained by cross-linking with glutaraldehyde at
shorter incubation times). When Hsp104 was cross-linked at a
concentration of 0.01 mgyml, most of the protein migrated as a
monomer. When ATP was present, cross-linking yielded hex-
amers at all of these protein concentrations. Gel filtration
chromatography and multiangle light scattering confirmed that
Hsp104 was hexameric at high protein concentrations and
existed as a combination of monomers and dimers at low protein
concentrations (D. Hattendorf and S.L, unpublished results).
For simplicity, we refer to the latter state as ‘‘unassembled.’’
We next asked if high protein concentrations could overcome
the oligomerization defects of Hsp104 NBD2 point mutants (Fig.
1B), which fail to assemble at ATP concentrations at which the
WT protein is fully assembled (10, 11). One of these, K620T,
carries a threonine substitution in the conserved lysine of the
P-loop motif that interacts directly with the b- and g-phosphates
of bound nucleotide in other nucleotide-binding proteins with
this motif (21); the other, G619V, is a glycine to valine substi-
tution in residue 619 (Fig. 1B). Previously, only K620T was tested
at a protein concentration of 0.01 mgyml. It was unassembled
even in the presence of 5 mM ATP (10, 11). Here, for both of
these mutants, some assembly was observed at a protein con-
centration of 0.05 mgyml; at 0.5 mgyml, nearly all of the protein
was hexameric (Fig. 1C and data not shown). Note that proteins
carrying analogous mutations in NBD1, K218T, G217V, and a
new double mutant K218T:A315T with severe defects in ATPase
activity assembled in the presence of ATP even at low protein
concentrations (Fig. 1C and data not shown).
The Relationship Between Hexamerization and ATP Hydrolysis in the
NBD2 Mutants. Next, we asked if overcoming the assembly defect
of NBD2 mutants would also overcome their ATP hydrolysis
defects. At protein concentrations of 0.01 to 0.02 mgyml and an
ATP concentration of 5 mM, the K620T and G619V proteins
hydrolyzed ATP at ’1y20th the rate of WT Hsp104 (10). At
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higher protein concentrations, the rate of ATP hydrolysis in-
creased dramatically, reaching 40–80% of WT levels at 0.5
mgyml (Fig. 2 and data not shown).
The two proteins that carried analogous P-loop substitutions
in NBD1, K218T and G217V (10) failed to hydrolyze detectable
amounts of ATP at any protein concentration tested (Fig. 2 and
data not shown). The same was true for the double mutant
K218T:A315T. Another mutant, not previously described, car-
ried a threonine to alanine substitution adjacent to the P-loop
lysine in NBD2, T621A. In the presence of ATP, this mutant
assembled into hexamers, even at low protein concentrations
(Fig. 1C). Its ATPase activity was lower than WT protein but did
not change at any of the concentrations tested (Fig. 2). These
data suggest that the increase in ATP hydrolysis with the G619V
and K620T proteins at high concentrations results from over-
coming their assembly defects.
Kinetic Analysis of Mutant and WT Proteins. To determine what
parameters of ATP hydrolysis are affected by assembly, the Vmax
and Km values for ATP hydrolysis were determined at different
protein concentrations. At the highest and lowest concentra-
tions, linearity was lost over the broad range of ATP concen-
trations required for these assays, but at protein concentrations
between 0.02 and 0.1 mgyml, ATPase activity remained linear
from 500 mM to 25 mM. As determined by cross-linking, most
K620T or G619V protein was in the unassembled form at 0.02
mgyml; most was in the hexameric form at 0.1 mgyml (data not
shown). For WT Hsp104 at 0.1 and 0.02 mgyml, the Km and Vmax
values were similar (Fig. 3; Table 1). For K620T, the Vmax
increased at the higher protein concentration. However, no
further increase in Vmax occurred when the protein concentration
was further increased from 0.1 to 0.25 mgyml (ATPase activity
remained in the linear range for K620T at 0.25 mgyml). That is,
once this mutant protein assembled, Vmax did not continue to
increase as the protein concentration increased.
Because WT Hsp104 forms hexamers even at very low protein
concentrations when ATP is present, we used a different exper-
imental approach to examine the effects of assembly on ATP
hydrolysis. As determined by glutaraldehyde cross-linking (Fig.
4A) and by sizing chromatography (J. R. Glover and S.L.,
unpublished observations), the assembly of WT Hsp104, in the
presence of ATP, can be manipulated with the zwitterionic
detergent CHAPS. WT Hsp104 assembles into hexamers in 2
Fig. 1. Assembly of Hsp104 proteins. (A) Effect of high protein concentra-
tions on the assembly of WT Hsp104 into hexamers. WT Hsp104 protein at
different concentrations was incubated at 37°C with glutaraldehyde in the
presence or absence of ATP for 2 or 12 min. Cross-linked proteins were
separated on SDS/3.5% polyacrylamide gels and stained with silver. Intramo-
lecular cross-links increased the mobility of monomers indicated by brackets.
In the absence of ATP, most Hsp104 was unassembled when cross-linked at low
protein concentrations but hexameric (indicated by asterisks) when cross-
linked at high protein concentrations. In the presence of ATP, Hsp104 was
hexameric at both protein concentrations. (B) General structural features of
Hsp104 and the location of mutations used in this study. Sequence regions that
are highly conserved in the HSP100 family, including the Walker A and B
motifs, are indicated by thicker lines. The P-loop (Walker A) consensus se-
quences are given, and positions of mutations therein are indicated by arrows.
(C) Effects of protein concentration on the assembly of mutant Hsp104 pro-
teins. Mutant proteins (0.01, 0.05, or 0.5 mgyml) were incubated with 5 mM
ATP, cross-linked with glutaraldehyde for 0 or 12 min, and analyzed as above.
The K218T:A315T and G217V mutants, like WT, hexamerize at all protein
concentrations, but the K620T and G619V mutants hexamerize only at high
protein concentrations. Unlike the other NBD2 mutants, the T621A mutant
did not exhibit an assembly defect.
Fig. 2. Effects of protein concentration on the ATPase activity of mutant
Hsp104 proteins. ATPase assays were performed with 5 mM ATP, using the
Malachite Green colorimetric assay to measure released phosphate. The same
buffer conditions were used as in cross-linking studies with different concen-
trations of Hsp104. The endpoints of reactions were varied to keep them in the
linear range of the assay and subsequently adjusted to min21. Mutant activity
is shown as the % of WT activity in the same experiment; mean and standard
deviations are shown. WT Hsp104 released 0.67, 0.77, 1.10, 0.89, 1.02, and 0.80
nmol of Pi min21 mg21, respectively, at 0.01, 0.02, 0.05, 0.1, 0.25, and 0.5
mgyml. ATP hydrolysis by the K218T:A315T and G217V mutants was negligible
at all protein concentrations, but the low hydrolysis by the K620T and G619V
mutants increased more than 10-fold at high protein concentrations. No
change occurred in the T621A mutant, which was oligomerized at all protein
concentrations.
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mM CHAPS (below the critical micelle concentration) but not
in 10 mM CHAPS (just above the critical micelle concentration).
When assembly of WT Hsp104 was inhibited with CHAPS, ATP
hydrolysis was reduced, albeit not as strongly as in the unas-
sembled K620T (Fig. 4B). Notably, however, reducing the
CHAPS concentration to 2 mM to promote assembly had the
same effect as increasing the protein concentration of the K620T
protein; it increased the rate of hydrolysis by increasing Vmax
severalfold. Together, these data indicate it is the rate of
turnover that is most affected when Hsp104 assumes a hexameric
form rather than the affinity for ATP (at least at the site, or sites,
responsible for the majority of ATP hydrolysis under these
conditions).
ATP Hydrolysis Is Cooperative in Hexameric Hsp104. One mechanism
by which the interaction between Hsp104 subunits might in-
crease the rate of ATP hydrolysis is through cooperativity, with
ATP hydrolysis at one site increasing the likelihood of hydrolysis
at another. Positive cooperativity should produce a Hill coeffi-
cient greater than 1. A series of kinetic assays were performed
over a broad range of ATP concentrations (10 mM to 40 mM)
at a concentration where both WT Hsp104 and K620T were
hexameric. For each protein, the Hill coefficient was repeatedly
between 1.5 and 2 (Fig. 5). Apparently, subunit interactions in
Hsp104 produce cooperativity in ATP hydrolysis, identifying at
least one factor that influences the rate of hydrolysis upon
assembly. They further indicate that oligomerization restores
some of the basic parameters of cooperative hydrolysis in the
K620T mutant.
The Role of Cooperativity in Hsp104 Function. To investigate the
importance of cooperative subunit interactions in vivo, we sought
conditions by which it could be blocked in a biological context.
The mutant K218T:A315T was the logical choice to pursue this
aim. It virtually eliminated ATP hydrolysis, yet it efficiently
assembled into hexamers, both on its own and in the presence of
WT Hsp104 protein (by glutaraldehyde cross-linking, data not
Fig. 3. Kinetic analysis of ATP hydrolysis. K620T and WT proteins at different
protein concentrations. Phosphate released was determined after 4 min at the
high protein concentration (0.1 mgyml) and after 16 min at the low protein
concentration (0.02 mgyml) to ensure that reactions were within the linear
range of the assay. Assays were performed in the same buffer as cross-linking
studies (Fig. 1A) at 37°C. The rate of hydrolysis was calculated from the
nanomoles of phosphate released by 0.5 mg of Hsp104 (0.02 mgyml) during the
first 5 min of incubation with ATP at various concentrations. Km and Vmax
values were determined by least squares fitting to the Michaelis–Menten
equation by using the KALEIDAGRAPH program (Synergy Software). Kinetic
properties of the WT protein are similar at both protein concentrations, but
for the K620T mutant Vmax values increased 4-fold at the higher protein
concentration.
Table 1. Km and Vmax values calculated for the K620T and WT
proteins at two different protein concentrations
Protein
Conc.,
mgyml
Km,
mM
Vmax, nmol
min21mg21
K620T 0.02 2.3 0.06
0.10 2.5 0.25
WT 0.02 4.8 1.25
0.10 5.9 1.28
Vmax is in nmol of Pi released per min per mg of protein.
Fig. 4. Effects of the zwitterionic detergent CHAPS on the hexamerization
and ATPase activities of WT Hsp104. (A) Cross-linking assays were performed
as in Fig. 1A, in the presence of 2 mM or 10 mM CHAPS. Assembly was inhibited
at the higher detergent concentration. (B) Kinetic analysis of WT Hsp104 in the
presence of CHAPS. WT Hsp104 (0.02 mgyml) was incubated for 16 min and Km
and Vmax values were calculated as in Fig. 3. In different experiments, the Vmax
for ATP hydrolysis was 2- to 4-fold less in 10 mM CHAPS (hexameric, dashed
line) than in 2 mM CHAPS (unassembled), whereas Km was changed less than
2-fold.
Fig. 5. Cooperativity of ATP hydrolysis. Kinetic analysis of K620T mutant and
WT Hsp104 (0.25 mgyml) ATP hydrolysis at ATP concentrations ranging from
20 mM to 32 mM. ATP hydrolysis was cooperative, yielding a Hill coefficient of
’2.2 (standard error 0.2) for K620T and ’1.7 (standard error 0.2) for WT. The
rate of hydrolysis was calculated during the first 4 min of incubation with ATP
for WT and 7 min for K620T to ensure that reaction products were measurable
within the linear range of the assay. The Hill coefficients were calculated by
fitting the nonlinear curves from plotting millimolar ATP vs. nmol of Pi
released min21 mg21 to the Michaelis–Menten equation by using the allosteric
kinetic equation of the GRAFIT 4 graphics program (Erithacus Software) and
were similar to those calculated from the slope of the linear Hill plots shown.
Schirmer et al. PNAS u January 30, 2001 u vol. 98 u no. 3 u 917
BI
O
CH
EM
IS
TR
Y
shown). Coassembly with K218T:A315T should block coopera-
tive ATP hydrolysis by WT Hsp104. Thus, the rate of ATP
hydrolysis in mixed oligomers of K218T:A315T and WT Hsp104
should decrease as the concentration of K218T:A315T is in-
creased. Indeed, addition of increasing amounts of
K218T:A315T to a fixed quantity of WT protein (0.5 mg)
decreased, but did not eliminate, ATP hydrolysis (Fig. 6A).
Inhibition plateaued at a mutant to WT ratio of 5:1 (for which
the rate of hydrolysis is similar to that obtained by including
CHAPS in the reactions to prevent oligomerization). This was
not due to competition for substrate, as ATP was in excess, nor
was it due to the change in protein density because (i) the
addition of BSA in place of K218T:A315T did not inhibit
hydrolysis by Hsp104, (ii) the addition of WT Hsp104 in place of
K218T:A315T increased hydrolysis in a linear manner, and (iii)
the addition of K620T to WT Hsp104 increased the total ATPase
activity in a nearly additive manner (data not shown). Thus, we
conclude that excess K218T:A315T blocks cooperative ATP
hydrolysis by WT Hsp104. At its maximum effect, this block in
cooperativity is not so strong as to eliminate hydrolysis; it simply
reduces it approximately 2-fold.
Next, we examined the effects of excess K218T:K315T on WT
Hsp104 in vivo. We have previously shown that K218T is unable
to provide thermotolerance in the absence of WT Hsp104 but
has no deleterious effects on growth (20). Cells coexpressing
K218T and WT Hsp104 at similar levels had normal levels of
thermotolerance (D. A. Parsell and S.L., unpublished observa-
tions). However, very little functional Hsp104 is required for
thermotolerance (28, 29). Thus, those Hsp104 hexamers that do
not contain sufficient K218T:A315T to block cooperative ATP
hydrolysis by WT Hsp104 could well be sufficient for thermo-
tolerance. In light of our observation that a 5-fold excess of
K218T:A315T is required to maximize the effects of this mutant
on the ATPase activity of WT Hsp104 in vitro (Fig. 6A), we
engineered the expression of K218T:A315T such that the
K218T:A315TyWT ratio would be ’5 in vivo. In this case,
thermotolerance was reduced dramatically. In the absence of
heat shock, high levels of the K218T:A315T protein had no
adverse effect on growth in either cells expressing WT Hsp104
or cells carrying an HSP104 deletion (Fig. 6B, NO HS; data not
shown). Moreover, the K218T:A315T mutant did not reduce the
low level of residual thermotolerance that is present in hsp104
deletion cells after a conditioning preheat treatment (data not
shown). Because the K218T:A315T mutant had no deleterious
effects on its own, we suggest that the decrease in thermotoler-
ance it produces in the presence of WT Hsp104 is due to the
ability of this mutant to alter the activity of the WT protein in
mixed oligomers.
The K620T mutant was also assayed in vivo. In the absence of
WT Hsp104, overexpressing K620T had no deleterious effects on
growth. However, overexpression of K620T in the presence of
WT Hsp104 caused some growth inhibition at normal temper-
atures (data not shown), preventing testing of the effect of
K620T on the thermotolerance function of WT Hsp104. None-
theless, it provides independent evidence of the importance of
subunit interactions in regulating Hsp104 function in vivo.
Discussion
We have shown that the activities of Hsp104 are strongly
influenced by subunit interactions, both in vitro and in vivo. In
experiments where the hexameric form of WT Hsp104 was
controlled by the detergent CHAPS or the hexameric form of
NBD2 mutants was controlled by protein concentration, ATP
hydrolysis was higher in the assembled state than in the nonas-
sembled state by about 4-fold. In both cases, this was primarily
due to an increase in Vmax. We have also determined that
hydrolysis is cooperative in Hsp104, thereby identifying a con-
tributing factor for increased hydrolysis in the assembled state.
Our data further suggest that cooperativity and subunit inter-
actions are vital to the thermotolerance function of Hsp104
in vivo.
Earlier work had indicated functional distinctions between the
two NBDs of Hsp104 (10, 11); NBD1 mutations virtually elim-
inate hydrolysis without affecting assembly, whereas analogous
mutations in NBD2 severely affect assembly while reducing
hydrolysis ’10-fold. We now find that high protein concentra-
tions overcome the assembly defects of NBD2 mutants and at the
same time increase the rate of ATP hydrolysis to 40–80% that
of the WT. Together with earlier data, these observations argue
strongly that NBD1 is responsible for most of the ATPase
activity of the protein, whereas nucleotide binding or hydrolysis
at NBD2 regulates structural parameters that affect NBD1
activity (for example, in response to substrate and cofactor
interactions). It remains possible that both sites contribute more
equally to hydrolysis. If so, the ATPase activities of the two
domains must be coupled in such a way that the basal activity of
NBD2 strongly depends on the activity of NBD1, but the basal
activity of NBD1 is relatively independent of NBD2 activity
when the protein is assembled.
If most ATP hydrolysis occurs at NBD1, then the Hill
coefficient of ’2 likely ref lects cooperative hydrolysis be-
tween NBD1 subunits in the hexamer rather than between
NBD1 and NBD2. This idea is further supported by the
allosteric interactions we observed by inhibiting WT Hsp104
ATPase activity in mixed oligomers, an effect that has also
been observed for the related ClpA protein (22). Furthermore,
a residue in the C terminus that is highly conserved among all
HSP100 proteins was shown to interact with a conserved
P-loop residue of an adjacent subunit in oligomers of HslU,
another member of the HSP100 protein family (30). And in
separate work, we have found that the affinity of NBD2 for
ATP is 100-fold greater than that of NBD1 (D. Hattendorf
and S.L., unpublished results). Most of the kinetic parameters
Fig. 6. Effect of the K218T:A315T mutant protein on WT Hsp104. (A)
Different concentrations of K218T:A315T were added to a fixed quantity of
WT protein (0.5 mg per reaction, 0.02 mgyml), and phosphate release was
determined as in Fig. 2. K218T:A315T inhibited WT ATPase activity, reaching
maximum inhibition at ’5-fold excess. (B) Effect of the K218T:A315T protein
on the biological activity of WT Hsp104. Cells had an integrated, constitutive
K218T:A315T expression plasmid or the vector control and an estradiol-
inducible WT HSP104 expression plasmid or the vector control. WT Hsp104 was
induced to ,20% the level of K218T:A315T for 2 h at 25°C. Levels of Hsp104
protein before heat shock are shown for equal numbers of cells beneath the
NO HS panel. Cells were serially diluted (5-fold each step) and plated to
determine survival at 25°C before (No HS) or after (HS) a 4-min heat shock at
50°C. Constitutive expression of K218T:A315T had no adverse affect on
growth in the absence of heat shock but blocked the increase in survival
produced by WT Hsp104 after heat shock.
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of ATP hydrolysis examined here ref lect the effects of ATP
binding to the lower affinity site, NBD1.
Unlike HslU, which has only one NBD and a C-terminal
region, Hsp104 has two NBDs flanked by N-terminal, middle,
and C-terminal regions. Thus, a large number of interactions
between domains and subunits is possible. Indeed, we have
found that the rate of ATP hydrolysis increases substantially
when polypeptides are bound to the C terminus of Hsp104 and
that the middle region of Hsp104 appears to play an important
role in mediating changes in NBD1 activity in response to
C-terminal interactions (A. Cashikar, E.C.S., D.M.W., and S.L.,
unpublished data). This middle region of Hsp104 and other
HSP100 proteins that function in thermotolerance is long,
whereas that of the HSP100yClp proteins that function in
proteolysis is much shorter or absent; thus, the middle region’s
effects on the ATPase reaction cycle may distinguish these
functions. In separate work, we have found that the rate of ATP
hydrolysis in assembled Hsp104 is increased in low salt buffers
(10). In that case, the increase in hydrolysis specifically reflected
a change in the Km measured by ATP hydrolysis. In contrast, the
effects of oligomerization reported here specifically affect Vmax.
Taken together, this work suggests that the two NBDs of Hsp104
work together in a complex cycle that involves multiple ATP
binding and hydrolysis states, which may be influenced by many
interactions within the hexamer and with substrates.
In addition to demonstrating that cooperativity and oligo-
meric contacts influence the parameters of ATP hydrolysis by
Hsp104, we have established that these contacts profoundly
influence the function of the protein in living cells. Unlike many
other chaperones, WT Hsp104 is not toxic to growth even when
it is overexpressed at very high concentrations (28, 29). The fact
that K620T slightly inhibits growth at normal temperatures, but
only in the presence of WT protein, suggests correct subunit
interactions are normally required to control the biological
activities of Hsp104. Further, when the K218T:A315T mutant
was expressed in the presence of WT Hsp104 at a ratio equiv-
alent to that which maximally inhibits WT Hsp104 ATP hydro-
lysis in vitro, it strongly inhibited the thermotolerance function
of WT Hsp104 in vivo. Yet, the K218T:A315T mutant had no
toxic effects on its own. The observations reported here provide
a biological confirmation of earlier biochemical suggestions that
the two NBDs of Hsp104 have different functional roles. They
also indicate that correct subunit interactions in the hexameric
form are vital for thermotolerance function. This was by no
means a forgone conclusion. K218T:A315T reduced the free-
running ATPase activity of WT Hsp104 in mixed oligomers by
only ’2-fold, and we have previously shown that a very small
quantity of Hsp104 is sufficient for thermotolerance (28). Yet,
even larger quantities of WT Hsp104 are insufficient for ther-
motolerance when cooperative subunit interactions are per-
turbed by the induction of K218T:A315T. The conditional
expression of this protein will provide an important tool for the
analysis of Hsp104 function in the maintenance of yeast prions
and the aggregation-prone human disease proteins such as
huntingtin.
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